New JerseyProhibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2024
- Feb 12Introduced in the Assembly, Referred to Assembly Health CommitteeIntroduced